Medical network on August 3 - the current medical market public medical institutions still occupy the market share of 75%, while the two giants in the field of private medical competition pattern is forming, the two sides competing high-end layout, plot by differentiation competition for market share of public hospitals.
August 1, icahn group and western medicine group, the intelligent technology, announced by introducing IBMWatson for Oncology (cancer) Watson cognitive computing solutions, will be icahn group, 108 IBM Watson tumor medical cooperation with medical center construction consultation center.
It is also the first time that IBM Watson's intelligent medical care system has been introduced into China's preventive care system. Wu yi-do, head of marketing for IBM Watson Health in greater China, believes that the partnership between baiyang and aikang could lead to a real link between Health management and smart healthcare.
In icahn group founder, chairman and CEO Zhang Ligang view, after 20 years of development, China's private medical center is no longer a supporting role in the industry, China's private medical centers and public hospital medical center will share the responsibility of preventive medical services, but if just do the routine inspection health service model not extend its value will be limited.
In fact, with the arrival of ciming physical examination in the us, the pattern of private physical examination has gradually formed, and both sides are actively positioning the high-end market. Not long ago, aikang guobin announced that it would lay out high-end and post-inspection markets. The health of the United States has also issued a notice twice in the us, saying that the high-end medical examination business.
Comprehensive layout of smart medical care
After someone in the "tube" strategic upgrade medical conference reached a strategic cooperation, formally icahn group will introduce IBM Watson for Oncology (cancer) Watson cognitive computing solutions, and 108 medical and health center to build the IBM Watson tumor consultation center.
It is also the first time that IBM Watson's intelligent medical care system has been introduced into China's preventive care system. In the future, the two sides will also have in-depth cooperation on the Watson for Genomics solution.
It is understood that the new intelligent technology in the first half of this year have received Watson for Oncology (cancer), Watson, and Watson for Genomics (Watson) exclusive distribution rights in China, and Watson Health priority negotiation and GeZuoQuan in other products.
So far, the intelligent technology has 13 triple comprehensive medical institutions in eight provinces and cities set up Watson tumor consultation center, the national universal coverage will pass this and other major provinces and cities icahn group cooperation greatly accelerated.
The western medicine group chairman FuGang to reporter said that the 21st century economy, under the existing public hospital system, currently a good technology, need experts put forward requirements, dean goes through the examination and approval, management, involving charge need local price department for examination and approval. As a private institution, aikang group is more flexible, and the cooperation can accelerate the intellectualized change in the field of cancer prevention and control.
FuGang pointed out that China is now about 430 new cancer patients each year, 5 years of survival rate is only 37%, equivalent to half that in America, one of the reasons and prevention of health related, because no valid certificate was done early screening, early detection; Another reason is that because of the high quality of medical resources at home, many local patients have not standardized treatment plans.
"Artificial intelligence will make a great contribution in the field of medical treatment, patients with artificial intelligence can be based on individual behavior, psychological factors, past medical history, such as genetic information to produce more thinking, and through the analysis of huge amounts of data, early screening out trace tumor and provide more accurate recommendations for the treatment of tumor." "Said Mr. Fu.
IBM Watson Health, general manager of greater China marketing Wu Yiduo also said hope can realize for cancer is more precise and more personalized evidence-based treatment, get through the chain of Health management and intelligent medical.
In zhang's opinion, the physical examination and treatment in China has been out of line for a long time. "People after a medical examination after cancer diagnosis, find appropriate professional medical resources, and standardization of treatment plan, unified control precision preventive health care and treatment, is the need to improve the health care industry system proposition."
To this end, the aikang group recently put forward the strategic upgrade of "some people tube". And in accordance with the iKangCare + plan, the future after the icahn medical diagnosis of cancer patients, will receive aikang free choose 3 armour hospital experts across the country for the second scheme evaluation consultation and diagnosis and treatment, but also by Watson tumor diagnosis center for the world's top expert team give treatment, treatment effectively improve accuracy and efficiency of service.
High end, post-inspection market
Mr Zhang believes that the use of artificial intelligence and big medical data will drive unprecedented changes across the healthcare industry.
In the industry, medical industry service content in the future will be done by conventional health check-up transition to the comprehensive development of health management, at the same time, the medical service of personalized, customized, specialized medical institutions gradually become the main market.
After more than 20 years of development, China's private medical center is no longer a supporting role in the industry, China's private medical center and public hospital medical center jointly bear the responsibility to prevent medical services. It is understood that more than half of the physical examination in Beijing is done in the private physical examination center.
However, according to the China hospital association, the domestic physical examination market is still dominated by state-owned enterprises, despite the fact that private companies are active. Great Wall securities analyst how-ran chao said in a research report also pointed out that in the current medical market participants include public hospital check-up, private medical institutions, the public medical institutions market share of about 75%, approximately more than 7000 private medical center, the market is relatively scattered.
Shi lichen, founder of the company, believes that consumer trust in public hospitals is still high. From a business point of view, the future of private medical aspects of the business in the most likely volumes is a personal business, but to achieve rapid growth, in talent accumulation, detection technology, service level, the level of diagnosis and treatment, etc., there is still a long way to go.
Zhang Ligang to 21st century business herald reporters that icahn group over the years has been the main high-end market, using the differentiation competition with public hospitals, icahn also in check-up packages to upgrade the high incidence of cancer on the basis of the solution.
For the early screening of gastric cancer and colorectal cancer, aikang "gastroenterology" introduced China's first fecal helicobacter pylori genotyping test and the fecal DNA test of early screening of bowel cancer. For early screening of lung cancer in China with the first cancer incidence, aikang "lung bao bao" contains the liquid biopsy, lung CT, gene detection and other items that can be screened for early lung cancer. For more comprehensive cancer screening and early disease risk assessment, icahn Campbell "king" contains the male 197, female 202 a full set of genetic testing, 18 species of high incidence of cancer liquid biopsy and lung CT detection method, etc.
In fact, in addition to icahn group in overweight layout high-end market, another big health also private medical giant in active layout, health beauty years, according to the announcement on June 15, to 100 million yuan investment with self-owned capital to set up a wholly owned subsidiary of Shanghai beauty genial health management co., LTD., built to cover professional medical, slow high-end medical examination, high-end medical treatment, disease management and so on the omni-directional health management system.
With the years of big acquisitions ciming health check-up, icahn group, the United States in at present big healthy competition is forming, the two giants and both sides in the layout of the high-end, differentiation competition for market share of public hospitals. In the industry's view, this will promote the consolidation of the private medical examination industry, and the future market concentration will increase further.
In Shi Lichen point of view, the current domestic demand for high-end medical examination is increase year by year, including the domestic year and icahn in high-end market layout, and after checking the market management of chronic diseases and health management will become the new growth opportunities. But in the past, the high-end projects of private medical examination are far from Europe, America and Japan, and it is worth observing whether the high-end transformation can be effective. |
